­ANTIBODY COMPOSITIONS AND OPTIMIZATION METHODS

­ANTIBODY COMPOSITIONS AND OPTIMIZATION METHODS  

Researchers at Stanford have invented a method using directed evolution for predicting antibody improved antibody variants.

Evolution searches across an immense space of possible sequences for rare mutations that improve fitness. In nature, this search is based on random mutation and recombination, but using this same approach for directed evolution of proteins in the laboratory imposes a considerable experimental burden. Indeed, current approaches are limited as high-throughput evolutionary screens, that rely on random guessing or brute-force search, often devote substantial effort to interrogating weakly active or nonfunctional proteins. There is therefore a need for more efficient and effective methods of generating protein variants using directed evolution.

Stage of Research

The inventors have developed methods for predicting improved antibody variants. Such variants can be used (or selected) to improve properties of known therapeutic antibodies in methods described herein. The present disclosure is also based, in part, on antibody variants designed using the provided methods that are able to specifically bind to viral antigens.

Applications

  • Predicting a small, manageable set (~10) of high-likelihood protein variants from a single antibody sequence using the predictive capabilities of protein language models.
  • Additional characterization of evolved antibodies to find variants with higher binding affinity and higher thermostability.

Advantages

  • Exploring a mutational space which is multiple orders of magnitude larger than is possible with in vivo evolutionary trajectories.
  • The computational portion of this approach takes seconds, whereas traditional methods employed by the state-of-the-art (rounds of cell culture and sorting) takes weeks.

Stage of Development

Research – in vitro

Publications

Brian L. Hie, Varun R. Shanker, Duo Xu, Theodora U. J. Bruun, Payton A. Weidenbacher, Shaogeng Tang, Wesley Wu, John E. Pak, Peter S. Kim. Nature Biotechnology (2023). doi.org/10.1038/s41587-023-01763-2. Efficient evolution of human antibodies from general protein language models.

Related Web Links

https://peterkimlab.stanford.edu/

Keywords

Antibody, variant

Technology Reference

Biohub ref. no. CZB-245S-PC

Stanford ref. no. S22-130

Patent Information: